← All trials
NCT04981379
Phase 3Interventional
Includes trials conducted after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 16, 2020
- Primary completion
- Jan 31, 2021
- Completion date
- Feb 16, 2021
- First posted
- Jul 29, 2021
- Last posted
- Jul 29, 2021
- Enrollment
- 1120
- Arms / groups
- 4 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Government of TurkeyLead sponsor
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.